This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Conglomerate 3M’s focus on business transformation — with moves like the localization of decision making and integration of supply chains — enhances its competitive advantage. Also, its recognized product brands and investments in innovation are compelling. Inorganic actions (buyouts and divestments) are added advantages. Acelity, bought in October 2019, is predicted to aid 3M’s medical solutions business. Being one of the largest manufacturers of respiratory masks, the coronavirus outbreak has added to the company’s growth potential.
Will 3M (MMM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
3M (MMM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Invest in Neogen (NEOG) Stock Now
by Zacks Equity Research
Neogen's (NEOG) better-than-expected Q2 revenues and robust growth across Food Safety & Animal Safety businesses instill investor confidence.
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $181.02 in the latest trading session, marking a +0.89% move from the prior day.
Carlisle (CSL) Gains From Solid Demand and Buyout Synergies
by Zacks Equity Research
Carlisle (CSL) seems a good investment option. It boasts healthy product demand, synergistic gains from buyouts, solid product offerings and a focus on product introductions.
Danaher (DHR) Q4 Sales to Exceed Guidance on Healthy Demand
by Zacks Equity Research
Danaher (DHR) communicates that its fourth-quarter 2021 sales performance is better than previously expected as solid demand in all three segments drives the performance.
3M (MMM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $177.41 in the latest trading session, marking a -1.41% move from the prior day.
3M (MMM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $177.74, moving +0.06% from the previous trading session.
3M (MMM) to Gain From End-Market Strength, Risks Persist
by Zacks Equity Research
3M (MMM) is poised to benefit from strength in its end markets, solid portfolio of products, and shareholder-friendly policies. Pandemic-related uncertainties and a high debt level pose concerns.
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $177.64, marking a +0.53% move from the previous day.
3M (MMM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $172.92 in the latest trading session, marking a +0.16% move from the prior day.
3M (MMM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $172.64, moving -1.21% from the previous trading session.
NEOGEN (NEOG) Gains on 3M's Food Safety Arm Merger Deal
by Zacks Equity Research
According to NEOGEN (NEOG), apart from the United States and Europe, substantial interest among developing nations to improve food safety presents significant growth potential for the combined company.
3M (MMM) to Divest Food Safety to NEOGEN in Tax-Friendly Deal
by Zacks Equity Research
3M's (MMM) food safety business combined with NEOGEN will create a global leader in the food security market, with expanded offerings, market presence and innovation capabilities.
Company News for Dec 15, 2021
by Zacks Equity Research
Companies In The News Are: TSLA, TMX, NEOG, MMM, PFE.
3M (MMM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $174.58, moving -1.42% from the previous trading session.
3M (MMM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
3M (MMM) closed at $176.55 in the latest trading session, marking a -0.37% move from the prior day.
The Zacks Analyst Blog Highlights: Tesla, Meta Platforms, Abbott Lab, Comcast and 3M
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tesla, Meta Platforms, Abbott Lab, Comcast and 3M
Top Analyst Reports for Tesla, Meta Platforms & Abbott Laboratories
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), Meta Platforms, Inc. (FB), and Abbott Laboratories (ABT).
3M (MMM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $170.73, moving +0.41% from the previous trading session.
Why Is 3M (MMM) Down 0.3% Since Last Earnings Report?
by Zacks Equity Research
3M (MMM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How Are Industrial ETFs Reacting to Mixed Q3 Earnings?
by Sweta Jaiswal, FRM
The industrial sector is expected to rebound from the coronavirus-led slump as the U.S. economy is expected to keep recovering in the rest of 2021.
3M (MMM) Q3 Earnings and Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
3M's (MMM) third-quarter 2021 revenues increase 7.1% year over year on account of impressive performance across its segments.
3M (MMM) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
3M (MMM) delivered earnings and revenue surprises of 12.39% and 3.18%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
3M (MMM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, 3M (MMM) closed at $180.80, marking a -0.72% move from the previous day.
3M (MMM) Gears Up to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
3M (MMM) Q3 earnings are likely to reflect gains from product offerings, demand and improving economic conditions. High raw material and logistics costs, and supply-chain woes are likely to have hurt.